Skip to content
InsideEdge
Investors / filer profile

No completed buy history yet — outcomes appear once a disclosed buy is ~6 months old.

Disclosed positions

Estimated from their latest filings — positions may have changed since

$13.21M
combined est. value

Activity

Open-market buy & sell volume

BuySell
0$2.2M$4.4M2025 · bought $0 · sold $4.4M20252026 · bought $0 · sold $2.9M2026
Total +$0.0000 bought · $7.36M sold

All filings on record

Every Form 4 transaction we track for this filer

MDGLSell
2026-05-22 · MADRIGAL PHARMACEUTICALS, INC.
$41.6K
MDGLSell
2026-05-22 · MADRIGAL PHARMACEUTICALS, INC.
$405.7K
MDGLSell
2026-05-22 · MADRIGAL PHARMACEUTICALS, INC.
$774.8K
MDGLSell
2026-05-22 · MADRIGAL PHARMACEUTICALS, INC.
$373.7K
MDGLSell
2026-05-22 · MADRIGAL PHARMACEUTICALS, INC.
$339.0K
MDGLSell
2026-05-22 · MADRIGAL PHARMACEUTICALS, INC.
$176.5K
MDGLSell
2026-05-22 · MADRIGAL PHARMACEUTICALS, INC.
$20.5K
MDGLSell
2026-05-22 · MADRIGAL PHARMACEUTICALS, INC.
$225.0K
MDGLSell
2026-05-22 · MADRIGAL PHARMACEUTICALS, INC.
$312.0K
MDGLSell
2026-05-22 · MADRIGAL PHARMACEUTICALS, INC.
$77.1K
MDGLSell
2026-05-22 · MADRIGAL PHARMACEUTICALS, INC.
$162.6K
MDGLSell
2026-05-22 · MADRIGAL PHARMACEUTICALS, INC.
$20.3K
MDGLExercise
2026-02-23 · MADRIGAL PHARMACEUTICALS, INC.
$18.4K
KNSAExercise
2026-02-01 · Kiniksa Pharmaceuticals International, plc
683
MDGLExercise
2026-01-26 · MADRIGAL PHARMACEUTICALS, INC.
$65.8K
MDGLSell
2025-11-13 · MADRIGAL PHARMACEUTICALS, INC.
$21.2K
MDGLSell
2025-11-13 · MADRIGAL PHARMACEUTICALS, INC.
$232.6K
MDGLSell
2025-11-13 · MADRIGAL PHARMACEUTICALS, INC.
$105.6K
MDGLSell
2025-11-13 · MADRIGAL PHARMACEUTICALS, INC.
$63.2K
MDGLSell
2025-11-13 · MADRIGAL PHARMACEUTICALS, INC.
$80.2K
MDGLSell
2025-11-13 · MADRIGAL PHARMACEUTICALS, INC.
$424.7K
MDGLSell
2025-11-13 · MADRIGAL PHARMACEUTICALS, INC.
$749.6K
MDGLSell
2025-11-13 · MADRIGAL PHARMACEUTICALS, INC.
$570.8K
MDGLSell
2025-11-13 · MADRIGAL PHARMACEUTICALS, INC.
$160.4K
MDGLSell
2025-11-13 · MADRIGAL PHARMACEUTICALS, INC.
$704.1K

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.